EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Acotec Scientific Holdings's Enterprise Value is HK$1,400.3 Mil.
Acotec Scientific Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-101.2 Mil. Therefore, Acotec Scientific Holdings's EV-to-FCF for today is -13.83.
The historical rank and industry rank for Acotec Scientific Holdings's EV-to-FCF or its related term are showing as below:
HKSE:06669'
s EV-to-FCF Range Over the Past 10 Years
Min: -170.83 Med: -22.22 Max: 1.61
Current: -15.31
During the past 5 years, the highest EV-to-FCF of Acotec Scientific Holdings was 1.61. The lowest was -170.83. And the median was -22.22.
HKSE:06669's EV-to-FCF is ranked worse than 100% of 361
companies
in the Medical Devices & Instruments industry
Industry Median: 28.78
vs HKSE:06669: -15.31
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Acotec Scientific Holdings's EV-to-FCF
For the Medical Devices subindustry, Acotec Scientific Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acotec Scientific Holdings's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Acotec Scientific Holdings's EV-to-FCF falls into.
Acotec Scientific Holdings's current Enterprise Value is HK$1,400.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acotec Scientific Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-101.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Acotec Scientific Holdings's PE Ratio for today is calculated as:
Acotec Scientific Holdings's share price for today is HK$6.73.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acotec Scientific Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.055.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Acotec Scientific Holdings EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Acotec Scientific Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Acotec Scientific Holdings (HKSE:06669) Business Description
Acotec Scientific Holdings Ltd is a medical device company. The company is focused on providing leave nothing behind treatment solutions for vascular diseases. It has developed a suite of interventional medical devices featuring world- leading technologies, notably in the fields of drug-coated balloons and thrombus aspiration catheters. The company's commercialized product is Semi-compliant PTCA Balloon (YAN) is a product designed for dilation in coronary artery or coronary artery bypass vessels stenosis to improve myocardial perfusion. Geographically, the company operates from Mainland China, Europe and Other countries and regions. Majority of revenue is generated from Mainland China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:06669 has been successfully added to your 